Dr. Christopher Brady Bledsoe, MD

Dr. Bledsoe practices at SurgiCenter of Murfreesboro Medical Clinic in Murfreesboro, Tennessee.

Dr. Bledsoe's NPI, 1770875205, was assigned on May 3, 2011. Dr. Bledsoe graduated from University of Tennessee, Hsc, College of Medicine in 2011. Dr. Bledsoe holds Tennessee license 52614.

Dr. Bledsoe's primary practice is SurgiCenter of Murfreesboro Medical Clinic, at 1272 Garrison Drive, Murfreesboro, TN 37129. The practice phone is (615) 893-4480.

Dr. Bledsoe's primary practice is SurgiCenter of Murfreesboro Medical Clinic in Murfreesboro, Tennessee. The medical group on file is Murfreesboro Medical Clinic & SurgiCenter. Dr. Bledsoe's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bledsoe practices. Vendor and product names are available with a free account.

Dermatology is Dr. Bledsoe's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Bledsoe is licensed in Tennessee.

CMS data shows 3,231 Medicare services from Dr. Bledsoe across 23 procedure codes in 2024, for 802 Medicare patients. Medicare paid $133,960 for them. Every service was in an office.

CMS counts 802 Medicare patients who saw Dr. Bledsoe in 2024. The largest group is 65 to 74, with 444 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.91, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bledsoe's median patient age at 64, with 47% women.

In 2024, Dr. Bledsoe wrote 886 Medicare Part D claims for 436 patients. 99% of them were for generic drugs. CMS names the drug for 792 of them, across 19 drugs with 11 or more claims each, at $18,534 in total drug cost. In 2023, CMS named 705 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Bledsoe for performance year 2024, reported through an alternative payment model (APM). Dr. Bledsoe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 544 procedures of skin biopsy by Dr. Bledsoe, more than 96% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1,067 general payments to Dr. Bledsoe from 49 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Abbvie Inc. paid the most, $3,180.

Dr. Bledsoe graduated from University of Tennessee, Hsc, College of Medicine in 2011.